Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...

This may limit the access further as insulin delivery from pen devices is preferred by a huge majority of diabetics over vials injected with syringes, due to its accuracy, ease of dosing ...

a vial costs anywhere from $7 to $14, significantly less than the United States. “Honestly, we believe [insulin manufacturers] are violating consumer protection laws, the RICO statute ...

After just 48 hours of drug exposure, the cells began producing insulin and responding to glucose—just like normal beta cells do. Related Stories Common diabetes drugs may protect against ...

A group of experts updated the FITTER insulin injection recommendations for the first time since 2016. The report includes new guidance on needle size and the angle at which injections should be ...

The Ninja range is Kawasaki’s primary breadwinner not just in India but globally as well. The Japanese superbike brand doesn’t like too many changes but constantly keeps making small updates ...

However Mixtard in India will continue to be available in vials. Along with it, other form of insulin including human insulin from Novo Nordisk will continue to be available in vials & devices for ...

Speaking of the design, the 2025 Kawasaki Ninja 650 comes with a similar silhouette to the outgoing model. However, the livery of the updated model comes as a fresh one. The outgoing model gets ...

By Michael D. Shear Reporting from London Seven pediatric doctors and toxicology experts said on Thursday that jurors were misled by prosecutors who cited unreliable insulin tests during the trial ...

A recent study found that the homeostasis model assessment insulin resistance (HOMA-IR), quantitative insulin-sensitivity check index (QUICKI), and fasting glucose/insulin ratio (FGIR) were ...